| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0008-6363(03)00429-2 |
| P698 | PubMed publication ID | 12909321 |
| P50 | author | Hugo A. Katus | Q27929168 |
| Mathias Müller | Q39677181 | ||
| P2093 | author name string | Matthias Müller | |
| Norbert Frey | |||
| Oliver J Müller | |||
| Wolfgang M Franz | |||
| Mathias Lange | |||
| Cordula Bittner | |||
| Henning Rattunde | |||
| Warner Simonides | |||
| Hans-Peter Lorenzen | |||
| P433 | issue | 2 | |
| P921 | main subject | overexpression | Q61643320 |
| P304 | page(s) | 380-389 | |
| P577 | publication date | 2003-08-01 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload | |
| P478 | volume | 59 |
| Q35812855 | A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q53269263 | Alterations in the expression of genes related to contractile function and hypertrophy of the left ventricle in chronically paced patients from the right ventricular apex. |
| Q33683757 | Altered intracellular Ca2+ handling in heart failure |
| Q35116100 | Altered myocardial calcium cycling and energetics in heart failure--a rational approach for disease treatment |
| Q36837270 | Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy |
| Q36984701 | Ca2+ clearance and contractility in vascular smooth muscle: evidence from gene-altered murine models |
| Q37076149 | Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure |
| Q26798131 | Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells |
| Q54378688 | Carnitine modulates crucial myocardial adenosine triphosphatases and acetylcholinesterase enzyme activities in choline-deprived rats. |
| Q34695565 | Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a |
| Q33626525 | Cytosolic H2O2 mediates hypertrophy, apoptosis, and decreased SERCA activity in mice with chronic hemodynamic overload. |
| Q35825891 | Decreased cardiac SERCA2 expression, SR Ca uptake, and contractile function in hypothyroidism are attenuated in SERCA2 overexpressing transgenic rats |
| Q37299072 | Designing heart performance by gene transfer. |
| Q37187366 | Diastolic heart failure: mechanisms and controversies |
| Q36198962 | Differential calcium handling in two canine models of right ventricular pressure overload |
| Q43892725 | Doxycycline inducible expression of SERCA2a improves calcium handling and reverts cardiac dysfunction in pressure overload-induced cardiac hypertrophy |
| Q92982557 | Effect of Valsartan on Sarcoplasmic Reticulum Ca2+-ATPase Pump of the Left Ventricular Myocardium in Rats with Heart Failure with Preserved Ejection Fraction |
| Q36507315 | Effects of Growth Hormone on Cardiac Remodeling During Resistance Training in Rats |
| Q34467075 | Enhanced L-type calcium currents in cardiomyocytes from transgenic rats overexpressing SERCA2a |
| Q57030935 | Epigallocatechin-3 gallate prevents pressure overload-induced heart failure by up-regulating SERCA2a via histone acetylation modification in mice |
| Q83554578 | Evaluation of left ventricular mechanical work and energetics of normal hearts in SERCA2a transgenic rats |
| Q53540868 | Expression of SERCA isoform with faster Ca2+ transport properties improves postischemic cardiac function and Ca2+ handling and decreases myocardial infarction. |
| Q39508627 | Hydralazine-induced promoter demethylation enhances sarcoplasmic reticulum Ca2+ -ATPase and calcium homeostasis in cardiac myocytes |
| Q51531441 | Hypertrophy induced KIF5B controls mitochondrial localization and function in neonatal rat cardiomyocytes. |
| Q51116860 | Impaired left ventricular mechanical and energetic function in mice after cardiomyocyte-specific excision of Serca2. |
| Q79190415 | Increased Ca2+ sensitivity and protein expression of SERCA 2a in situations of chronic beta3-adrenoceptor deficiency |
| Q46291758 | Increased expression of SERCA in the hearts of transgenic mice results in increased oxidation of glucose |
| Q46570729 | Left ventricular mechanical and energetic changes in long-term isoproterenol-induced hypertrophied hearts of SERCA2a transgenic rats |
| Q26823061 | Model-specific selection of molecular targets for heart failure gene therapy |
| Q43292300 | Moderate intensity of regular exercise improves cardiac SR Ca2+ uptake activity in ovariectomized rats |
| Q90290390 | Novel Insight Into the Epigenetic and Post-transcriptional Control of Cardiac Gene Expression by Thyroid Hormone |
| Q28579882 | Opposing roles of FoxP1 and Nfat3 in transcriptional control of cardiomyocyte hypertrophy |
| Q85848255 | Persistent overexpression of SERCA2a affects bladder functions under physiological conditions, but not in bladder outlet obstruction-induced sub-acute pathological conditions |
| Q36628719 | Phospholamban overexpression in transgenic rabbits |
| Q37054922 | Role of sarco/endoplasmic reticulum calcium content and calcium ATPase activity in the control of cell growth and proliferation |
| Q64086755 | SPEG, an Indispensable Kinase of SERCA2a for Calcium Homeostasis |
| Q46683454 | Short-term effects of pressure overload on the expression of genes involved in calcium homeostasis |
| Q53580927 | Targeted gene transfer increases contractility and decreases oxygen cost of contractility in normal rat hearts. |
| Q35763705 | Targeting cardiomyocyte Ca2+ homeostasis in heart failure |
| Q60913186 | Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction |
| Q37229784 | The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases |
| Q37118557 | The non-excitable smooth muscle: calcium signaling and phenotypic switching during vascular disease |
| Q38416973 | Therapeutic Molecular Phenotype of β-Blocker-Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy. |
| Q40199219 | Treatment of heart failure by calcium cycling gene therapy |
| Q37793527 | What Causes a Broken Heart—Molecular Insights into Heart Failure |
| Q79846175 | [Reverse remodeling of the intracellular Ca(2+)-homeostasis: new concepts of pathophysiology and therapy of heart failure] |
Search more.